The Milestone of 20,000 Followers

We just passed an important milestone as the Facebook channel of Omixon has over 20,000 followers now and our community is constantly growing. Your support is really appreciated and we hope this is a sign of you enjoying the content we provide day by day.

You can also follow us on Twitter and please stay tuned for many interesting events and campaigns we are going to launch soon!

The Milestone of 20,000 Followers

Omixon’s Breakfast Seminar at ASBMT

Come and join  Omixon for a breakfast seminar at to learn about the benefits of using next generation sequencing  for transplantation genetics.

You will learn how to reduce ambiguity, increase resolution of HLA typing at an affordable price point. The presentation will also address the challenges current early adopters face with NGS and its limitations and how current developments address these challenges. Continue reading <span class="meta-nav">→</span>

The Long Indel Contest

In order to raise awareness of biological importance of insertions and deletions as genomic variants, we have introduced a scientific challenge: The Long Indel Contest.

The goal is to find long insertions and deletions up to 1024 base pairs in length, based on human Next Generation Sequencing (NGS) data and reference based alignment. Find the longest insertion or deletion using human genomic data with one of the standard human reference genomes (hg18, hg19) and win US$500. Continue reading <span class="meta-nav">→</span>

Screencast about Omixon

Here is a short screencast about Omixon Target, the main product of Omixon, an application suite developed with a vision of helping clinical labs to adopt next generation sequencing for the analysis of diagnostic gene targets. There will be new, more detailed screencasts soon.

Omixon will be attending American Society of Bone and Marrow Transplantation Salt Lake City, 13-17 February 2013

The American Society for Blood and Marrow Transplantation is an international professional association that promotes the advancement of the blood and marrow transplantation field.  ASBMT members are both in clinical practice, in research, and health professionals. From its beginning, ASBMT activities have been representing the interests of transplant clinicians and investigators and the patients they serve  like fostering research and development of transplantation both as a science and a therapy. Continue reading <span class="meta-nav">→</span>